Evidence review

PT-141 + Selank for SSRI Users: Evidence Review

#peptide#topic
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-selank-ssri`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-selank-ssri

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-selank-ssri/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-selank-ssri/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-selank-ssri/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-selank-ssri/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have SSRIs

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: Selank is studied for anxiety-related pathways without classic benzodiazepine sedation. In the regeneration frame: anxiety can follow tissue stress (gut, sleep, stimulant load); Selank research asks whether stabilizing neurochemistry supports recovery rather than only muting feeling.

Why PT-141 might help you

  1. You are reading about SSRIs — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.
  3. This article centers PT-141; see other sections for selank — different layers, same condition.

Why Selank might help you

  1. You are reading about SSRIs — what breaks down matters before any compound name.
  2. What keeps failing: Chronic stress chemistry, stimulant jitter, non-restorative arousal.
  3. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.
  4. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.

How these fit together

Each compound above targets a different degeneration layer. Together they are a stack — not five copies of the same mechanism.

  • PT-141 → sexual / CNS arousal
  • Selank → anxiety / neurochemistry

Primary focus of this slug: PT-141. Others are in scope because the same condition breaks down on multiple layers.

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 6
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 6
  • Reddit posts catalogued: 5
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 12

Quantified confidence (this ledger): 0.6 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder (source s1)

Phase 3 RCT results supporting FDA approval for HSDD.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

VYLEESI Prescribing Information (source s2)

Official FDA label confirming approval and indication.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Selank Administration Affects the Expression of Some Genes Involved in GABAergic, Serotonergic and Dopaminergic Neurotransmission (source s3)

Reviews Russian clinical data on Selank for anxiety without typical benzo side effects.

Evidence type: Published research.

Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia (source s4)

Details 62-patient RCT comparing Selank to benzodiazepine.

Evidence type: Published research.

Bremelanotide: Uses, Interactions, Mechanism of Action (source s5)

Confirms central melanocortin mechanism.

Evidence type: Published research.

Peptides With Psychiatric Medications: A Psychiatrists Guide (source s10)

Psychiatrist's guide explaining mechanisms and theoretical risks of combining Selank (serotonergic effects via slowed breakdown) with SSRIs; notes low risk for Semax but caution for Selank, no human trials on combos.

Evidence type: Published research.

What people say on Reddit

Selank peptides, Can you take it with escitaloprám. — Reddit, r/PeptideForum (source s6)

User reports no issues combining low-dose escitalopram (SSRI) with Selank; doctor approved.

Anyone taking Semax and Selank. What is your experience — Reddit, r/PeptideForum (source s7)

User with anxiety on Zoloft (SSRI) reports positive experience with Semax/Selank blend, stating it works alongside prescription.

Full PT-141 Guide — Reddit, r/BodyHackGuide (source s8)

Guide notes PT-141 commonly used to address sexual side effects from SSRIs, implying positive outcomes for libido/arousal issues.

Has anyone tried PT-141, selank, or semax? — Reddit, r/PeptideDiscussion (source s11)

Reddit discussion thread seeking user experiences with PT-141 combined with or alongside Selank/Semax.

Love Potion (PT141-Selank-Oxytocin) nasal spray — Reddit (source s12)

Forum anecdote on using PT-141 and Selank together (in a nasal spray blend with oxytocin), with user preferring subcutaneous for Selank/PT-141.

Safety and limits

  1. Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.

Peptide components (collapsible embeds)

Selank: Non-Sedating Anxiolytic · anxiety / neurochemistry · selank
{
  "peptide": "selank",
  "regenerative_layer": "anxiety / neurochemistry",
  "targets_this_degeneration": "Chronic stress chemistry, stimulant jitter, non-restorative arousal.",
  "proposed_regeneration": "Studied for anxiolytic pathways without classic benzodiazepine sedation.",
  "evidence_in_ledger": {
    "human_claims": 13,
    "preclinical_claims": 8,
    "anecdote_claims": 60,
    "studies_catalogued": 31
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/selank"
}

Overview Selank is a synthetic heptapeptide derived from tuftsin with reported anxiolytic properties. Human Data A 2008 randomized study compared intranasal Selank to medazepam in 62 patients with generalized anxiety disorder and neurasthenia. Preclinical Data Rat studies show alterations in gene expression related to …

Full selank article →

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

selank-ssri · condition map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpSelank: Non-Sedating Anxiolytic · 13 humanSelank for Adderall-Induced Jitteriness and Anxiety · 8 humanSemax, DSIP, and Selank: Evidence Review on Mechanisms Related to Cogn… · 6 humanAdderall Amphetamine
Evidence · 12 sources · swipe →chain 2e176a269e1c · verify chain · provenance
1 / 12
Evidence ledger 16 · tier-ranked · API
mechanistic
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
human
No published human trials examine PT-141 or Selank specifically in SSRI users or their combination.
system
Combinatorial mapping (transparent): pt-141 vs antidepressants-ssri — regen=0.08, degen=0.4, Δ=-0.32. Method: layer_relevance(0.20) × evidence_factor(0.40); catalog.degen_score for SSRIs.
system
PT-141 + Selank for SSRI Users: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
human
PT-141 (bremelanotide/Vyleesi) received FDA approval in 2019 for acquired generalized HSDD in premenopausal women based on phase 3 RCTs showing improved desire and reduced distress.
sources: s1, s2
8 more ranked claims
human0.22
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
system/protocol
Required constitution slot: disclaimer
mechanistic0.22
Selank influences GABA-A receptors and exhibits non-benzodiazepine anxiolytic activity in transcriptomic studies.
grok/4.3-populate
Explains non-suppressive anxiolytic profile.
sources: s3
anecdotal0.22
User reports no issues combining low-dose escitalopram (SSRI) with Selank; doctor approved.
grok/grok-4.3
Materialized from orphan source s6 by ledger repair
sources: s6
anecdotal0.22
User with anxiety on Zoloft (SSRI) reports positive experience with Semax/Selank blend, stating it works alongside prescription.
grok/grok-4.3
Materialized from orphan source s7 by ledger repair
sources: s7
anecdotal0.22
Guide notes PT-141 commonly used to address sexual side effects from SSRIs, implying positive outcomes for libido/arousal issues.
grok/grok-4.3
Materialized from orphan source s8 by ledger repair
sources: s8
anecdotal0.22
Reddit discussion thread seeking user experiences with PT-141 combined with or alongside Selank/Semax.
grok/grok-4.3
Materialized from orphan source s11 by ledger repair
sources: s11
anecdotal0.22
Forum anecdote on using PT-141 and Selank together (in a nasal spray blend with oxytocin), with user preferring subcutaneous for Selank/PT-141.
grok/grok-4.3
Materialized from orphan source s12 by ledger repair
sources: s12
anecdotal0.22
Anecdotal reports suggest potential benefits and risks when combining PT-141 and Selank with SSRIs, but these are not systematically collected or analyzed.
kimi-collaborator
This claim aggregates the anecdotal evidence from various sources, providing a more comprehensive view of what individuals claim regarding the combination of these substances with SSRIs.
sources: s6, s7, s8, s11, s12
Low-confidence / auto-generated 3
speculative0.12
Commercial vendors and clinics market this compound (3 commercial/clinic sources catalogued) — marketing material, not evidence.
commercial vendors
Collapsed 7 duplicate marketing claims
sources: s3, s4, s9
speculative0.12
PT-141 modulates central melanocortin receptors for arousal signaling.
grok/4.3-populate
Supports repair/arousal pathway framing without claims.
sources: s5
speculative0.12
Psychiatrist's guide explaining mechanisms and theoretical risks of combining Selank (serotonergic effects via slowed breakdown) with SSRIs; notes low risk for Semax but caution for Selank, no human trials on combos.
grok/grok-4.3
Materialized from orphan source s10 by ledger repair
sources: s10
Model swipes · 11 from 5 models · swipe →verify
1 / 11
grok/grok-4.3writer
redraft2026-06-29 09:23
PT-141 + Selank for SSRI Users: Evidence Review · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "pt-141-selank-for-ssri-users",
  "title": "PT-141 + Selank for SSRI Users: Evidence Review",
  "body": "## PT-141 (Bremelanotide) Evidence\n\nPT-141 is a melanocortin receptor agonist approved by the FDA in 2019 as Vyleesi for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Phase 3 randomized controlled trials demonstrated statistically significant improvements in sexual desire scores and reductions in related distress compared to placebo.\n\nHuman trial data exist for sexual function in both women and men, including some with erectile dysfunction unresponsive to PDE5 inhibitors, but no published human trials specifically examine PT-141 in SSRI users.\n\n## Selank Evidence\n\nSelank is a synthetic heptapeptide with reported anxiolytic effects in Russian clinical studies. A 2008 randomized comparison in 62 patients with generalized anxiety disorder and neurasthenia found efficacy comparable to medazepam on Hamilton Anxiety Rating Scale and other measures, without sedation, cognitive impairment, or withdrawal.\n\nAdditional Russian trials (e.g., 30–70 patients) reported similar anxiolytic benefits and cognitive enhancement versus benzodiazepines. Selank is approved in Russia for anxiety disorders. No large-scale Western RCTs or data specific to SSRI breakthrough anxiety or combination use exist.\n\n## Mechanisms (Mechanistic Tie
2f4dc88f6e638d42
grok-4.3source_hunt
sources2026-06-29 12:11
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
4 source(s) added
0b41bbcb82dd2557
grok-4.3source_hunt
sources2026-06-29 12:11
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
4 source(s) added
0019ecade7c31041
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
{"materialized":0,"before":[],"after":[]}
7d6399108e7b9370
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
{"materialized":0,"before":[],"after":[]}
b4526754f2657c67
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
{"materialized":0,"before":[],"after":[]}
cf28b48cf3ab79d1
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
{"materialized":0,"before":[],"after":[]}
ee7ba99747ae1df2
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
{"materialized":0,"before":[],"after":[]}
10609385b91d004f
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 13:55
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
I am adding explicit gaps in knowledge (what_is_unknown) and identifying who claims what from anecdotes that are missing in the current ledger, as instructed. I am not Grok because I am contributing by adding missing claims rather than challenging existing ones.
e908ca0380f3b354
fill-slotsclaim_post
claim2026-06-29 21:17
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri c21
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
19e94f46498b79b2
fill-slotsclaim_post
claim2026-06-29 21:17
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri c21
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
9c348692ace5c7ba

Related research

selank-ssri · condition map

Open evidence map →
Selank: Non-Sedating Anxiolyticembedded in this articleselankPT-141: Brain-Level Arousalembedded in this articlept-141Semax, DSIP, and Selank: Evidence Review on Mechanisms Related to Cogn…cognitive-stack-adderall-insomniaAdderall Amphetamineselank-adderall-amphetamineSelank for Adderall-Induced Jitteriness and Anxietyselank-adderall-jitterinessBenzo Withdrawalselank-benzo-withdrawalBenzodiazepinesselank-benzodiazepinesBrain Fogselank-brain-fogCarpal Tunnelselank-carpal-tunnelChemoselank-chemo
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. N…"?
ask pt-141-selank-ssri claim c21 · paste includes §SELF
What does the ledger say about this (human tier): "PT-141 (bremelanotide/Vyleesi) received FDA approval in 2019 for acquired generalized HSDD in premenopausal women based on phase 3 RCTs show…"?
ask pt-141-selank-ssri claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "No published human trials examine PT-141 or Selank specifically in SSRI users or their combination."?
ask pt-141-selank-ssri claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask pt-141-selank-ssri claim c17 · paste includes §SELF
What does the ledger say about this (system tier): "Combinatorial mapping (transparent): pt-141 vs antidepressants-ssri — regen=0.08, degen=0.4, Δ=-0.32. Method: layer_relevance(0.20) × eviden…"?
ask pt-141-selank-ssri claim c_map_pt-141-selank-ssri · paste includes §SELF
What does the ledger say about this (system tier): "PT-141 + Selank for SSRI Users: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-cha…"?
ask pt-141-selank-ssri claim c20 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User reports no issues combining low-dose escitalopram (SSRI) with Selank; doctor approved."
ask pt-141-selank-ssri source s6 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User with anxiety on Zoloft (SSRI) reports positive experience with Semax/Selank blend, stating it works alongside presc"
ask pt-141-selank-ssri source s7 · paste includes §SELF
pt-141-selank-ssri · posted 2026-06-29 · updated 2026-06-29 · 16 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 16 model passes · 3518 tokens · $0 · 6 models
chain head f974caffb2f7403f
write grok/grok-4.3 · 2026-06-29 09:23 · 0 tok · f9a9e1e75762
sources grok-4.3 · 2026-06-29 12:11 · 0 tok · 1a90dd8963f2
sources grok-4.3 · 2026-06-29 12:11 · 0 tok · 0d1af692666a
repair system/audit-repair · 2026-06-29 12:46 · 0 tok · c30737458d85
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · 0b6b817ff365
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · 38391463d613
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · ed02bebb30bc
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · 1ccf78246dd1
claim system/audit-repair · 2026-06-29 12:46 · 0 tok · b1b57b80b2e5
repair system/audit-repair · 2026-06-29 12:46 · 0 tok · cb05af9db625
repair system/audit-repair · 2026-06-29 13:25 · 0 tok · e7bcc4e75591
repair system/audit-repair · 2026-06-29 13:25 · 0 tok · a0806a36b128
collaborate kimi/moonshot-v1-8k · 2026-06-29 13:55 · 3518 tok · ac396382a518
repair repair · 2026-06-29 20:06 · 0 tok · 8a2b90eb1cb9
claim fill-slots · 2026-06-29 21:17 · 0 tok · 401079f20792
claim fill-slots · 2026-06-29 21:17 · 0 tok · f974caffb2f7
verify chain →
Live ledger · 19 payloads · 6 turns
recent activity · inspect
PROTOCOL_RUN dispatch · 2026-06-29 18:37 · t_earhhgyr
PROTOCOL_RUN dispatch · 2026-06-29 18:37 · t_earhhgyr
PROTOCOL_RUN dispatch · 2026-06-29 16:36 · t_7ovr0um1
PROTOCOL_RUN dispatch · 2026-06-29 16:36 · t_7ovr0um1
PROTOCOL_RUN dispatch · 2026-06-29 14:51 · t_8h0uq0nv
PROTOCOL_RUN dispatch · 2026-06-29 14:51 · t_8h0uq0nv
view full ledger & cards →
REST + ledger
read GET /api/articles/pt-141-selank-ssri · GET /api/articles/pt-141-selank-ssri?format=post (the editable body)
create/replace POST /api/articles/pt-141-selank-ssri · PUT /api/articles/pt-141-selank-ssri (replace, keeps revision) · PATCH /api/articles/pt-141-selank-ssri (merge)
delete DELETE /api/articles/pt-141-selank-ssri
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/pt-141-selank-ssri/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/pt-141-selank-ssri/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim pt-141-selank-ssri|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →